美国 · SEC FORM 4
Bioventus Inc.
BVS · Nasdaq · CIK 0001665988 · Healthcare · Medical Devices
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
0 sales · 10 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2024-08-19 · Bartholdson John A. · $218.0K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Bartholdson John A.Director,TenPercentOwner
○
SUTTER MARTIN PDirector,TenPercentOwner
○
STALNECKER SUSAN MDirector
○
NOHRA GUY PDirector
○
NEELS GUIDO JDirector
○
McMurry-Heath MichelleDirector
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-08-19 · Bartholdson John A..
近期 Form 4 活动
0买入
3卖出
38其他 Form 4 交易行
25SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他10 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,161,332
- 上期报告
- 2,930,690
- 日均成交量
- 471,636
- 回补天数
- 6.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-08-19 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 25,500 | USD 8.55 | USD 218,025 | SEC 申报 ↗ |
| 2024-08-16 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 80,000 | USD 8.55 | USD 684,000 | SEC 申报 ↗ |
| 2023-08-18 | Bihl Anthony P III | 买入 (P) | Class A Common Stock | 39,885 | USD 4.14 | USD 165,124 | SEC 申报 ↗ |
| 2023-08-14 | Bartholdson John A.; Juniper Investment Company, LLC; MICHAS ALEXIS P | 买入 (P) | Class A Common Stock | 14,985 | USD 4.79 | USD 71,778 | SEC 申报 ↗ |
| 2023-08-14 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 14,985 | USD 4.79 | USD 71,778 | SEC 申报 ↗ |
| 2023-08-11 | Bartholdson John A.; Juniper Investment Company, LLC; MICHAS ALEXIS P | 买入 (P) | Class A Common Stock | 50,037 | USD 4.56 | USD 228,169 | SEC 申报 ↗ |
| 2023-08-11 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 50,037 | USD 4.60 | USD 230,170 | SEC 申报 ↗ |
| 2023-08-10 | Bartholdson John A.; Juniper Investment Company, LLC; MICHAS ALEXIS P | 买入 (P) | Class A Common Stock | 111,848 | USD 4.47 | USD 499,961 | SEC 申报 ↗ |
| 2023-08-10 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 111,848 | USD 4.47 | USD 499,961 | SEC 申报 ↗ |
| 2023-06-15 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 110,180 | USD 3.61 | USD 397,750 | SEC 申报 ↗ |
| 2023-06-14 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 181,946 | USD 3.24 | USD 589,505 | SEC 申报 ↗ |
| 2023-06-13 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 60,324 | USD 3.05 | USD 183,988 | SEC 申报 ↗ |
| 2023-06-12 | Bartholdson John A. | 买入 (P) | Class A Common Stock | 395,401 | USD 2.92 | USD 1,154,571 | SEC 申报 ↗ |
| 2023-05-25 | HAWKINS WILLIAM A | 买入 (P) | Class A Common Stock | 44,000 | USD 2.66 | USD 117,040 | SEC 申报 ↗ |
| 2023-05-24 | HAWKINS WILLIAM A | 买入 (P) | Class A Common Stock | 44,000 | USD 2.69 | USD 118,360 | SEC 申报 ↗ |
Form 4 申报证据
41 transaction lines in the latest 365-day window; 214 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | SUTTER MARTIN P | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | STALNECKER SUSAN M | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | NOHRA GUY P | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | SUTTER MARTIN P | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | STALNECKER SUSAN M | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | NOHRA GUY P | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | NEELS GUIDO J | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | McMurry-Heath Michelle | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Ladone Mary Kay | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | HAWKINS WILLIAM A | 期权行权／转换 (M) | Class A Common Stock | 39,789 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Cowdy Philip G. | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Beyer Pat | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Bartholdson John A. | 期权行权／转换 (M) | Class A Common Stock | 32,282 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-10 | Singleton Mark Leonard | 期权行权／转换 (M) | Class A Common Stock | 13,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-10 | Singleton Mark Leonard | 代扣税 (F) | Class A Common Stock | 5,648 | USD 9.06 | USD 51,171 | SEC 申报 ↗ |
| 2026-04-10 | D'Adamio Anthony | 期权行权／转换 (M) | Class A Common Stock | 9,925 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-10 | D'Adamio Anthony | 代扣税 (F) | Class A Common Stock | 4,312 | USD 9.06 | USD 39,067 | SEC 申报 ↗ |
| 2026-04-10 | CHURCH KATRINA J | 期权行权／转换 (M) | Class A Common Stock | 4,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-10 | CHURCH KATRINA J | 代扣税 (F) | Class A Common Stock | 1,868 | USD 9.06 | USD 16,924 | SEC 申报 ↗ |
| 2026-03-20 | Singleton Mark Leonard | 期权行权／转换 (M) | Class A Common Stock | 18,625 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-20 | Singleton Mark Leonard | 代扣税 (F) | Class A Common Stock | 8,091 | USD 8.64 | USD 69,906 | SEC 申报 ↗ |
| 2026-03-13 | Singleton Mark Leonard | 期权行权／转换 (M) | Class A Common Stock | 13,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | Singleton Mark Leonard | 代扣税 (F) | Class A Common Stock | 5,865 | USD 8.62 | USD 50,556 | SEC 申报 ↗ |
| 2026-03-13 | D'Adamio Anthony | 期权行权／转换 (M) | Class A Common Stock | 17,636 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | D'Adamio Anthony | 代扣税 (F) | Class A Common Stock | 7,663 | USD 8.62 | USD 66,055 | SEC 申报 ↗ |
| 2026-03-13 | Claypoole Robert E | 期权行权／转换 (M) | Class A Common Stock | 33,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | Claypoole Robert E | 代扣税 (F) | Class A Common Stock | 14,553 | USD 8.62 | USD 125,447 | SEC 申报 ↗ |
| 2026-03-13 | CHURCH KATRINA J | 期权行权／转换 (M) | Class A Common Stock | 6,955 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | CHURCH KATRINA J | 代扣税 (F) | Class A Common Stock | 3,022 | USD 8.62 | USD 26,050 | SEC 申报 ↗ |
| 2026-03-11 | McMurry-Heath Michelle | 卖出 (S) | Class A Common Stock | 12,000 | USD 8.79 | USD 105,480 | SEC 申报 ↗ |
| 2026-02-15 | Singleton Mark Leonard | 期权行权／转换 (M) | Class A Common Stock | 20,153 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-15 | Singleton Mark Leonard | 代扣税 (F) | Class A Common Stock | 9,429 | USD 8.27 | USD 77,978 | SEC 申报 ↗ |
| 2026-02-15 | D'Adamio Anthony | 期权行权／转换 (M) | Class A Common Stock | 12,980 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BVS |
| CIK | 0001665988 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 214 transaction lines from 2021-02-11 to 2026-06-02 26 P purchase lines · 50 S sale lines · 138 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.